Lexaria's Oral GLP-1 Drug Strategy Validated by Industry

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/4/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

Go back to Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
(NASDAQ: LEXX) Delayed: 2.88 -0.21 (6.8%)
Previous Close $3.09    52 Week High $ 
Open $3.18    52 Week Low $ 
Day High $3.24    P/E N/A 
Day Low $2.80    EPS $ 
Volume 81,262